Relafen 750, or Relafen, or Naproxcinod, or the medication represents a unique approach to pain management , viewed with a biochemical pharmacy perspective. A formulation, comprising naproxcinod, attempts to modulate cyclooxygenase (COX) activity, notably COX-2, even demonstrating reduced inhibition